These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production. Hsu LY; Chang SC; Luh KT; Hsieh WC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798 [TBL] [Abstract][Full Text] [Related]
4. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field]. Nishimura T; Tabuki K; Takashima T; Takagi M Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952 [TBL] [Abstract][Full Text] [Related]
5. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics]. Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076 [TBL] [Abstract][Full Text] [Related]
6. Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice. Gisby J; Wightman BJ; Beale AS Antimicrob Agents Chemother; 1991 May; 35(5):831-6. PubMed ID: 1854164 [TBL] [Abstract][Full Text] [Related]
7. [Clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules on skin and soft tissue infections in the field of pediatrics]. Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M Jpn J Antibiot; 1985 Feb; 38(2):507-37. PubMed ID: 3892077 [TBL] [Abstract][Full Text] [Related]
8. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections]. Hoshina H; Hirosawa H; Mikuni K; Ichihashi H Jpn J Antibiot; 1985 Feb; 38(2):309-18. PubMed ID: 3847520 [TBL] [Abstract][Full Text] [Related]
9. New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review. Sánchez Navarro A Clin Pharmacokinet; 2005; 44(11):1097-115. PubMed ID: 16231964 [TBL] [Abstract][Full Text] [Related]
10. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid. Steingrube VA; Wallace RJ; Brown BA; Pang Y; Zeluff B; Steele LC; Zhang Y Antimicrob Agents Chemother; 1991 Mar; 35(3):524-8. PubMed ID: 2039203 [TBL] [Abstract][Full Text] [Related]
11. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor. Smith BR; LeFrock JL Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282 [TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes. Fuglesang JE; Bergan T Infection; 1983; 11(6):329-35. PubMed ID: 6365790 [TBL] [Abstract][Full Text] [Related]
13. The cost effectiveness of amoxicillin/clavulanic acid as antibacterial prophylaxis in abdominal and gynaecological surgery. Davey PG; Parker SE; Crombie IK; Jaderberg M Pharmacoeconomics; 1995 Apr; 7(4):347-56. PubMed ID: 10172460 [TBL] [Abstract][Full Text] [Related]
14. [In vitro and in vivo activity of a combination of clavulanic acid and amoxicillin against Klebsiella pneumoniae producing extended broad-spectrum betalactamase (CTX-1, SHV-3, SHV-4)]. Migueres ML; Ronco E; Guenounou M; Philippon A Pathol Biol (Paris); 1989 May; 37(5):397-401. PubMed ID: 2674869 [TBL] [Abstract][Full Text] [Related]
15. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. Perry CM; Scott LJ Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560 [TBL] [Abstract][Full Text] [Related]